COMP <GO>
COYA vs TNXP // RSI-14 & 200D SMA MOMENTUM
Coya Therapeutics Inc. (NASDAQ) VS. Tonix Pharmaceuticals Holding Corp. (NASDAQ) • 15-METRIC TALLY: COYA 4
— TNXP 1
▲ RSI-14 & 200D SMA MOMENTUM LEADER: COYA
LAST: $3.61 (-9.30%) • MKT CAP: $93.4M
rsi-technicals
27.5
LAST: $5.10 (-3.41%) • MKT CAP: $90.6M
rsi-technicals
17.4
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (COYA VS. TNXP)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | COYA | TNXP | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | 49.30% | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | -35.00% | 0.00 | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -11.50% | — | — | TIE | /fcf-yield <GO> |
| Operating Margin | -60.00% | -60.00% | 0.00 | TIE | /operating-margins <GO> |
| Net Profit Margin | -60.00% | -60.00% | 0.00 | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | 123.60% | 29.80% | +93.80 | COYA | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 6.08 | 0.20 | +5.88 | COYA | /balance-sheet <GO> |
| Piotroski F-Score Quality | 3/9 | 5/9 | -2.00 | TNXP | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum ACTIVE | 27.5 | 17.4 | +10.08 | COYA | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $93.4M | $90.6M | $2.8M | COYA | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | COYA REV | TNXP REV | COYA GROSS % | TNXP GROSS % | COYA FCF | TNXP FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $7.9M | $13.1M | — | 49.3% | -$10.7M | -$103.2M |
| FY 2024 | $3.6M | $10.1M | — | 23.1% | -$10.3M | -$61.0M |
| FY 2023 | $6.0M | $7.8M | — | — | -$11.2M | -$102.0M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
COYA // BETA —
TNXP // BETA —